Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Resi
This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy.
| Condition(s) | Head & Neck Squamous Cell Carcinoma |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy. |
| Who can participate | Inclusion Criteria: * Adult patient ≥ 18 years of age * Presenting with head and neck squamous cell carcinoma * Completed curative treatment with external radiation therapy * Eligible for dynamic LAFOV FDG-PET scan for therapeutic evaluation at 3 months * Having given consent for the end-of-treatment consultation Exclusion Criteria: * Hypersensitivity to 18F-FDG or other excipients contained in the contrast agent * Pregnancy or breastfeeding * History of treated upper gastrointestinal tract cancer * Other histology * Incomplete RTE treatment regimen * Refusal to participate |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University Hospital, Brest |
| Locations | Brest, France |
| Start date | 2026-04-13 |
| NCT ID | NCT07417605 |
| Official listing | https://clinicaltrials.gov/study/NCT07417605 |